Altshuler Shaham’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Hold |
3,020
| – | – | 0.04% | 64 |
|
|
2025
Q1 | $1.46M | Hold |
3,020
| – | – | 0.04% | 50 |
|
|
2024
Q4 | $1.22M | Buy |
+3,020
| New | +$1.22M | 0.04% | 47 |
|
|
2024
Q3 | – | Sell |
-3,000
| Closed | -$1.41M | – | 351 |
|
|
2024
Q2 | $1.41M | Sell |
3,000
-655
| -18% | -$307K | 0.05% | 40 |
|
|
2024
Q1 | $1.53M | Sell |
3,655
-847
| -19% | -$354K | 0.06% | 34 |
|
|
2023
Q4 | $1.83M | Buy |
4,502
+4,435
| +6,619% | +$1.8M | 0.1% | 22 |
|
|
2023
Q3 | $23.3K | Sell |
67
-19
| -22% | -$6.61K | ﹤0.01% | 207 |
|
|
2023
Q2 | $30.3K | Buy |
+86
| New | +$30.3K | ﹤0.01% | 231 |
|
|
2023
Q1 | – | Sell |
-513
| Closed | -$148K | – | 454 |
|
|
2022
Q4 | $148K | Sell |
513
-184
| -26% | -$53.1K | 0.01% | 106 |
|
|
2022
Q3 | $204K | Sell |
697
-119
| -15% | -$34.8K | 0.01% | 123 |
|
|
2022
Q2 | $230K | Sell |
816
-225
| -22% | -$63.4K | ﹤0.01% | 119 |
|
|
2022
Q1 | $272K | Buy |
+1,041
| New | +$272K | ﹤0.01% | 182 |
|
|
2021
Q3 | – | Sell |
-140
| Closed | -$28K | – | 667 |
|
|
2021
Q2 | $28K | Buy |
+140
| New | +$28K | ﹤0.01% | 516 |
|
|
2020
Q4 | – | Sell |
-443
| Closed | -$121K | – | 468 |
|
|
2020
Q3 | $121K | Sell |
443
-1,248
| -74% | -$341K | ﹤0.01% | 161 |
|
|
2020
Q2 | $491K | Sell |
1,691
-505
| -23% | -$147K | 0.01% | 99 |
|
|
2020
Q1 | $523K | Buy |
2,196
+2,054
| +1,446% | +$489K | 0.02% | 83 |
|
|
2019
Q4 | $31K | Buy |
142
+82
| +137% | +$17.9K | ﹤0.01% | 217 |
|
|
2019
Q3 | $10K | Buy |
+60
| New | +$10K | ﹤0.01% | 282 |
|
|
2019
Q2 | – | Sell |
-44
| Closed | -$8K | – | 402 |
|
|
2019
Q1 | $8K | Sell |
44
-1
| -2% | -$182 | ﹤0.01% | 269 |
|
|
2018
Q4 | $7K | Buy |
+45
| New | +$7K | ﹤0.01% | 237 |
|